Results 21 to 30 of about 530,203 (233)

Clinical significance of anti-DFS70 in immunoinflammatory rheumatic diseases (review)

Научно-практическая ревматология, 2023
The relevance of the problem of immunoinflammatory rheumatic diseases (IIRD) for modern medicine is determined by their high prevalence in the population, the difficulty of early diagnosis, the rapid development of disability and poor life prognosis ...
T. A. Panafidina, Zh. G. Verizhnikova, A. S. Avdeeva, T. V. Popkova, E. L. Nasonov   +4 more
doaj   +1 more source

Nonsystemic vasculitic neuropathy

Medical Journal of Dr. D.Y. Patil Vidyapeeth, 2020
A 21-year-old female born of nonconsanguineous marriage presented with gradually progressive quadriplegia for 3 years. Weakness was distal more than proximal, with wasting. She also had moderate pain in extremities.
Shalesh Rohatgi, Dhaval Dave, Furqan Khan   +2 more
doaj   +1 more source

Antinuclear Antibodies in Patients with Psoriatic Arthritis Treated or Not with Biologics. [PDF]

PLoS ONE, 2015
With the emergence of biotherapies, accurate diagnosis in early arthritis is needed. At this time, there is no biological marker of psoriatic arthritis.To test whether antinuclear antibodies (ANA) can be used as a diagnostic tool in psoriatic arthritis ...
Florent Silvy, Daniel Bertin, Nathalie Bardin, Isabelle Auger, Marie-Caroline Guzian, Jean-Pierre Mattei, Sandrine Guis, Jean Roudier, Nathalie Balandraud   +8 more
doaj   +1 more source

Antinuclear Antibodies: A demographic profile from a Tertiary Healthcare Centre of Delhi

SVU - International Journal of Medical Sciences, 2023
Background: Anti-nuclear autoantibodies (ANA), have explicitly been linked to immune complex-mediated autoimmune diseases. Detection and quantitation of autoantibodies are therefore crucial in the diagnosis and treatment.
Krishna Sarkar, Nadeem Ahmad*, Debamita Banik, N. P. Singh   +3 more
doaj   +1 more source

Could Antinuclear Antibody Positivity Be a Factor Affecting Treatment Response in Immune Thrombocytopenia Patients on Eltrombopag?

Turkish Journal of Hematology, 2022
Objective: Eltrombopag remains a prominent option in the treatment of steroid-dependent or steroid-refractory immune thrombocytopenia (ITP) patients. Unfortunately, not all patients respond to eltrombopag.
Mehmet Baysal, Volkan Baş, Elif Ümit, Hakkı Onur Kırkızlar, Ahmet Muzaffer Demir   +4 more
doaj   +1 more source

Lupus-like nephritis with positive anti-neutrophil cytoplasmic antibodies and negative antinuclear antibodies

Brazilian Journal of Nephrology, 2020
Antineutrophil cytoplasmic antibodies (ANCAs) are associated with small vessel vasculitis but their prevalence is not rare in other immune diseases.
Joana Eugénio Santos, Rita Vicente, Beatriz Malvar, Iolanda Santos, Miguel Coimbra, Manuel Amoedo, Carlos Pires   +6 more
doaj   +2 more sources

Immunology markers that can be predictive for the diagnosis of juvenile idiopathic arthritis

Journal of Laboratory Medicine, 2020
This study aimed to investigate the implications of antinuclear antibodies (ANAs) in juvenile idiopathic arthritis (JIA), the association with uveitis and the favorable evolution of the disease.
Sur Lucia M., Silaghi Ciprian, Colceriu Marius C., Sur Daniel G., Aldea Cornel, Sur Genel, Floca Emanuela, Tataru Alexandru, Lupan Iulia, Samasca Gabriel   +9 more
doaj   +1 more source

CVID-associated TACI mutations affect autoreactive B cell selection and activation [PDF]

, 2013
Common variable immune deficiency (CVID) is an assorted group of primary diseases that clinically manifest with antibody deficiency, infection susceptibility, and autoimmunity.
Tuure Kinnunen, Gentile, M, Cantaert, T, Tineke Cantaert, Menard, L, Laurence Menard, Morbach, H, Saadoun, D, Virdee, M, Neil Romberg, Kinnunen, T, Maurizio Gentile, Rachid, R, Martinez-Pomar, N, Geha, R, Henner Morbach, Matamoros, N, Cunningham-Rundles, C, Nicolas Chamberlain, Nuria Matamoros, Andrea Cerutti, Yen Shing Ng, Bodo Grimbacher, Natalia Martinez-Pomar, Meffre, E, Eric Meffre, David Saadoun, Manmeet Virdee, Rima Rachid, Cerutti, A, Raif Geha, Romberg, N, Brimbacher, B, Chamberlain, N, Charlotte Cunningham-Rundles, Ng, YS   +35 more
core   +1 more source

Antinuclear antibodies in systemic sclerosis associated with increased risk of malignancy

Przegląd Dermatologiczny, 2018
Patients with systemic sclerosis are at 1.5–5-fold increased risk of developing malignant diseases. It has been shown that some types of antinuclear antibodies associated with systemic sclerosis may have predictive value for development of malignant ...
Anna Stochmal, Marta Sar-Pomian, Joanna Czuwara, Lidia Rudnicka   +3 more
doaj   +1 more source

Clinical diagnoses associated with a positive antinuclear antibody test in patients with and without autoimmune disease

BMC Rheumatology, 2023
Background Antinuclear antibodies (ANA) are antibodies present in several autoimmune disorders. However, a large proportion of the general population (20%) also have a positive test; very few of these individuals will develop an autoimmune disease, and ...
Jacy T. Zanussi, Juan Zhao, Wei-Qi Wei, Gul Karakoc, Cecilia P. Chung, QiPing Feng, Nancy J. Olsen, C. Michael Stein, Vivian K. Kawai   +8 more
doaj   +1 more source